This is the first time weight management has topped diabetes as the main reason. Users report eating fewer sweets, and 45% say they drink less alcohol.
Recap by typeshit. Full story at Supermarket News.
Osbourne says any medicine can be misused and connects Ozempic to the body image struggles he had when he was younger.
A one-line stock move for the maker of Mounjaro and Zepbound, with no reason given for the gain.
29:53
Journalist Scott Carney argues in favor of gray-market peptides. Only the title is available, so watch for his full reasoning and treat any health claims with caution.
The company announced exclusive manufacturing rights across its needle-free peptide products. Terms aren't given here.
The Warrington Guardian reports charges against staff over the theft of weight-loss injections valued at around £20,000.
The bank points to the international Oral Wegovy rollout and coming trial results as near-term catalysts, while flagging its Q3 earnings view.
Loading…